Optimizing epilepsy management: seizure control, medication tolerability, and co-morbidities
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Hagerstown, MD
Lippincott Williams & Wilkins
2002
|
| Series: | Neurology
58,8 Suppl. 5 |
| Subjects: | |
| Physical Description: | 39 S. graph. Darst. |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV014282392 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 020503s2002 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)49938783 | ||
| 035 | |a (DE-599)BVBBV014282392 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-20 | ||
| 050 | 0 | |a RC372 | |
| 245 | 1 | 0 | |a Optimizing epilepsy management |b seizure control, medication tolerability, and co-morbidities |c Frank Gilliam guest ed. |
| 264 | 1 | |a Hagerstown, MD |b Lippincott Williams & Wilkins |c 2002 | |
| 300 | |a 39 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Neurology |v 58,8 Suppl. 5 | |
| 650 | 4 | |a Comorbidity | |
| 650 | 4 | |a Epilepsy |x Chemotherapy | |
| 650 | 4 | |a Epilepsy |x Treatment | |
| 700 | 1 | |a Gilliam, Frank |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009794365 | ||
Record in the Search Index
| _version_ | 1804129173461008384 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV014282392 |
| callnumber-first | R - Medicine |
| callnumber-label | RC372 |
| callnumber-raw | RC372 |
| callnumber-search | RC372 |
| callnumber-sort | RC 3372 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)49938783 (DE-599)BVBBV014282392 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00915nam a2200301 cb4500</leader><controlfield tag="001">BV014282392</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020503s2002 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)49938783</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014282392</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC372</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Optimizing epilepsy management</subfield><subfield code="b">seizure control, medication tolerability, and co-morbidities</subfield><subfield code="c">Frank Gilliam guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hagerstown, MD</subfield><subfield code="b">Lippincott Williams & Wilkins</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">39 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neurology</subfield><subfield code="v">58,8 Suppl. 5</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Comorbidity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epilepsy</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epilepsy</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gilliam, Frank</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009794365</subfield></datafield></record></collection> |
| id | DE-604.BV014282392 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:00:56Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009794365 |
| oclc_num | 49938783 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-20 |
| physical | 39 S. graph. Darst. |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Lippincott Williams & Wilkins |
| record_format | marc |
| series2 | Neurology |
| spelling | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities Frank Gilliam guest ed. Hagerstown, MD Lippincott Williams & Wilkins 2002 39 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Neurology 58,8 Suppl. 5 Comorbidity Epilepsy Chemotherapy Epilepsy Treatment Gilliam, Frank Sonstige oth |
| spellingShingle | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities Comorbidity Epilepsy Chemotherapy Epilepsy Treatment |
| title | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities |
| title_auth | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities |
| title_exact_search | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities |
| title_full | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities Frank Gilliam guest ed. |
| title_fullStr | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities Frank Gilliam guest ed. |
| title_full_unstemmed | Optimizing epilepsy management seizure control, medication tolerability, and co-morbidities Frank Gilliam guest ed. |
| title_short | Optimizing epilepsy management |
| title_sort | optimizing epilepsy management seizure control medication tolerability and co morbidities |
| title_sub | seizure control, medication tolerability, and co-morbidities |
| topic | Comorbidity Epilepsy Chemotherapy Epilepsy Treatment |
| topic_facet | Comorbidity Epilepsy Chemotherapy Epilepsy Treatment |
| work_keys_str_mv | AT gilliamfrank optimizingepilepsymanagementseizurecontrolmedicationtolerabilityandcomorbidities |